NxStage Medical Debt to Equity Ratio 2006-2018 | NXTM

Current and historical debt to equity ratio values for NxStage Medical (NXTM) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. NxStage Medical debt/equity for the three months ending September 30, 2018 was 0.00.
NxStage Medical Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2018-09-30 $0.00B $0.23B 0.00
2018-06-30 $0.00B $0.22B 0.00
2018-03-31 $0.00B $0.22B 0.00
2017-12-31 $0.00B $0.21B 0.00
2017-09-30 $0.00B $0.21B 0.00
2017-06-30 $0.00B $0.22B 0.00
2017-03-31 $0.00B $0.21B 0.01
2016-12-31 $0.00B $0.20B 0.01
2016-09-30 $0.00B $0.20B 0.01
2016-06-30 $0.00B $0.20B 0.01
2016-03-31 $0.00B $0.20B 0.01
2015-12-31 $0.00B $0.19B 0.01
2015-09-30 $0.00B $0.19B 0.01
2015-06-30 $0.00B $0.19B 0.01
2015-03-31 $0.00B $0.19B 0.00
2014-12-31 $0.00B $0.19B 0.00
2014-09-30 $0.00B $0.19B 0.01
2014-06-30 $0.00B $0.19B 0.01
2014-03-31 $0.00B $0.19B 0.01
2013-12-31 $0.00B $0.20B 0.01
2013-09-30 $0.00B $0.20B 0.00
2013-06-30 $0.00B $0.20B 0.00
2013-03-31 $0.00B $0.20B 0.00
2012-12-31 $0.00B $0.20B 0.00
2012-09-30 $0.00B $0.20B 0.00
2012-06-30 $0.00B $0.20B 0.00
2012-03-31 $0.04B $0.15B 0.29
2011-12-31 $0.04B $0.15B 0.29
2011-09-30 $0.04B $0.15B 0.28
2011-06-30 $0.04B $0.15B 0.28
2011-03-31 $0.04B $0.15B 0.27
2010-12-31 $0.04B $0.15B 0.27
2010-09-30 $0.04B $0.08B 0.51
2010-06-30 $0.04B $0.08B 0.50
2010-03-31 $0.04B $0.08B 0.46
2009-12-31 $0.04B $0.09B 0.42
2009-09-30 $0.04B $0.10B 0.39
2009-06-30 $0.04B $0.10B 0.35
2009-03-31 $0.02B $0.11B 0.16
2008-12-31 $0.02B $0.12B 0.17
2008-09-30 $0.02B $0.13B 0.17
2008-06-30 $0.03B $0.13B 0.19
2008-03-31 $0.03B $0.12B 0.24
2007-12-31 $0.03B $0.13B 0.19
2007-09-30 $0.00B $0.06B 0.04
2007-06-30 $0.00B $0.08B 0.04
2007-03-31 $0.00B $0.09B 0.04
2006-12-31 $0.01B $0.08B 0.06
2006-09-30 $0.01B $0.09B 0.06
2006-06-30 $0.00B $0.10B 0.02
2006-03-31 $0.00B $0.06B 0.02
2005-12-31 $0.00B $0.07B 0.02
2005-09-30 $0.00B $-0.08B -0.03
2005-06-30 $0.00B $0.00B 0.00
2005-03-31 $0.00B $0.00B 0.00
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $1.977B $0.394B
NxStage Medical, Inc. is a medical device company, headquartered in Lawrence, Massachusetts, USA, that develops, manufactures and markets innovative systems for the treatment of end-stage renal disease, or ESRD, and acute kidney failure.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $131.725B 26.04
Medtronic (MDT) Ireland $124.003B 18.10
Stryker (SYK) United States $69.357B 25.46
Boston Scientific (BSX) United States $55.158B 26.93
Baxter (BAX) United States $39.096B 24.09
Zimmer Biomet Holdings (ZBH) United States $25.203B 16.17
Smith & Nephew SNATS (SNN) United Kingdom $16.703B 0.00
ResMed (RMD) United States $14.294B 27.11
Canopy Growth (CGC) Canada $10.770B 0.00
Bio-Rad Laboratories (BIO) United States $8.091B 51.74
Hill-Rom Holdings (HRC) United States $6.945B 21.48
Aurora Cannabis (ACB) Canada $6.920B 49.50
Perrigo (PRGO) Ireland $6.732B 10.22
ICU Medical (ICUI) United States $5.180B 28.86
Insulet (PODD) United States $5.177B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $4.529B 0.00
Haemonetics (HAE) United States $4.482B 39.76
Agios Pharmaceuticals (AGIO) United States $3.370B 0.00
Hutchison China MediTech (HCM) China $3.317B 0.00
Neogen (NEOG) United States $3.262B 50.11
NuVasive (NUVA) United States $2.949B 27.43
Quidel (QDEL) United States $2.670B 24.08
National Vision Holdings (EYE) United States $2.583B 49.97
Aphria (APHA) $2.429B 107.89
AtriCure (ATRC) United States $1.267B 0.00
Phibro Animal Health (PAHC) United States $1.231B 17.70
VAREX IMAGING (VREX) United States $1.213B 23.75
Cardiovascular Systems (CSII) United States $1.191B 854.75
HEXO (HEXO) $1.180B 0.00
MacroGenics (MGNX) United States $0.936B 0.00
Cerus (CERS) United States $0.886B 0.00
PetIQ (PETQ) United States $0.833B 21.60
Surmodics (SRDX) United States $0.773B 112.39
Lantheus Holdings (LNTH) United States $0.737B 19.96
Meridian Bioscience (VIVO) United States $0.728B 21.70
Evolus (EOLS) United States $0.725B 0.00
NanoString Technologies (NSTG) United States $0.718B 0.00
OraSure Technologies (OSUR) United States $0.707B 31.16
Omeros (OMER) United States $0.681B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.624B 20.02
Quanterix (QTRX) United States $0.505B 0.00
Owens & Minor (OMI) United States $0.494B 6.84
LeMaitre Vascular (LMAT) United States $0.492B 23.46
Insys Therapeutics (INSY) United States $0.418B 0.00
TG Therapeutics (TGTX) United States $0.398B 0.00
Utah Medical Products (UTMD) United States $0.339B 21.99
BioLife Solutions (BLFS) United States $0.322B 435.25
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.293B 0.00
Vapotherm (VAPO) United States $0.285B 0.00
Bovie Medical (APYX) United States $0.281B 0.00
Cytosorbents (CTSO) United States $0.259B 0.00
Rockwell Medical (RMTI) United States $0.253B 0.00
Zynex (ZYXI) United States $0.170B 16.42
Surface Oncology (SURF) United States $0.147B 0.00
Fonar (FONR) United States $0.146B 7.79
Chembio Diagnostics (CEMI) United States $0.116B 0.00
Chimerix (CMRX) United States $0.097B 0.00
United-Guardian (UG) United States $0.090B 18.77
Female Health (VERU) United States $0.085B 0.00
InfuSystems Holdings (INFU) United States $0.083B 0.00
CAS Medical Systems (CASM) United States $0.070B 0.00
Trinity Biotech (TRIB) Ireland $0.064B 17.80
Conatus Pharmaceuticals (CNAT) United States $0.057B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.057B 0.00
ImmuCell (ICCC) United States $0.039B 0.00
Neurotrope (NTRP) United States $0.034B 0.00
Senestech (SNES) United States $0.022B 0.00
Myomo (MYO) United States $0.017B 0.00
Capricor Therapeutics (CAPR) United States $0.013B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.013B 0.00
Akers Biosciences Inc (AKER) United States $0.011B 0.00
Valeritas Holdings (VLRX) United States $0.010B 0.00
Cellectar Biosciences (CLRB) United States $0.009B 0.00
NeuroMetrix (NURO) United States $0.008B 14.29